Chih Lung Shen
Direttore/Membro del Consiglio presso MEDEON BIODESIGN, INC.
Posizioni attive di Chih Lung Shen
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| MEDEON BIODESIGN, INC. | Direttore/Membro del Consiglio | 20/04/2015 | - |
| Independent Dir/Board Member | 20/04/2015 | - | |
| EIRGENIX INC. | Direttore/Membro del Consiglio | 06/12/2021 | - |
Cheng Xin Venture Capital Group
 Cheng Xin Venture Capital Group Investment ManagersFinance Cheng Xin Venture Capital Group (CXVCG) is a venture capital investment firm located in Taipei, Taiwan. Established in 1990, the firm manages a number of investment funds focusing on high technology and biotechnology firms. | Membro del Comitato di Investimento | - | - |
| Investitore di Private Equity | - | - | |
| Noratech Pharmaceuticals, Inc. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Chih Lung Shen
Precedenti posizioni note di Chih Lung Shen
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ASLAN PHARMACEUTICALS LIMITED | Direttore/Membro del Consiglio | 30/05/2016 | 30/10/2018 |
| LOTUS PHARMACEUTICAL CO., LTD. | Direttore/Membro del Consiglio | 01/06/2013 | 01/09/2014 |
| Independent Dir/Board Member | 01/06/2013 | 01/09/2014 | |
| TWI PHARMACEUTICALS INC | Direttore/Membro del Consiglio | 02/08/2012 | 01/06/2014 |
| TWI PHARMACEUTICALS INC | Direttore/Membro del Consiglio | 01/07/2017 | - |
Allgenesis Biotherapeutics, Inc.
 Allgenesis Biotherapeutics, Inc. BiotechnologyHealth Technology Allgenesis Biotherapeutics, Inc. is a Taiwanese clinical-stage biopharmaceutical company focused on researching and developing novel medicines for the treatment of eye diseases. The private company is based in Taipei, Taiwan. The company's current pipeline includes potential blockbuster drugs such as ag-73305 for the treatment of DME, NAMD, and other retinal diseases, as well as ag-80308 for dry eye disease. The company was founded by Chih Lung Shen and Chih Ming Chen. Madhu Cherukury has been the CEO of the company since 2014. | Fondatore | - | - |
| Presidente | 01/05/2014 | - | |
| ░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░ ░░░░░░░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░ ░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Formazione di Chih Lung Shen
| University of Wisconsin | Doctorate Degree |
| Tsinghua University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Taiwan | 12 |
| Singapore | 3 |
| Stati Uniti | 2 |
Posizioni
| Director/Board Member | 12 |
| Independent Dir/Board Member | 2 |
| Investment Committee Member | 1 |
Settori
| Health Technology | 10 |
| Consumer Services | 3 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 6 |
|---|---|
| MYCENAX BIOTECH INC. | Health Technology |
| LOTUS PHARMACEUTICAL CO., LTD. | Health Technology |
| MEDEON BIODESIGN, INC. | Electronic Technology |
| ASLAN PHARMACEUTICALS LIMITED | Health Technology |
| TWI BIOTECHNOLOGY, INC. | Health Technology |
| EIRGENIX INC. | Health Technology |
| Aziende private | 7 |
|---|---|
Cheng Xin Venture Capital Group
Cheng Xin Venture Capital Group Investment ManagersFinance Cheng Xin Venture Capital Group (CXVCG) is a venture capital investment firm located in Taipei, Taiwan. Established in 1990, the firm manages a number of investment funds focusing on high technology and biotechnology firms. | Finance |
Kiotek Corp.
 Kiotek Corp. BiotechnologyHealth Technology Kiotek Corp. researches, develops and manufactures chitosan based products. It offers biotechnological products such as chttins and chitosans that assist in weight loss. The company was founded in 1997 and is headquartered in Hsinchu, Taiwan. | Health Technology |
TWi Pharmaceuticals, Inc.
 TWi Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TWi Pharmaceuticals, Inc. operates as a technology-based special pharmaceutical company. The firm engages in the development and commercialization of high barrier generics drugs. Its products include donepezil hydrochloride tablets, megestrol acetate oral suspension, hydroquinone cream, guanfacine extended-release tablets and nifedipine extended-release tablets. The company was founded by Chih Ming Chen on December 1, 1997 and is headquartered in Taipei, Taiwan. | Health Technology |
| ARDIC Instruments Co. | |
ASLAN Pharmaceuticals Pte Ltd.
 ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | Health Technology |
Allgenesis Biotherapeutics, Inc.
Allgenesis Biotherapeutics, Inc. BiotechnologyHealth Technology Allgenesis Biotherapeutics, Inc. is a Taiwanese clinical-stage biopharmaceutical company focused on researching and developing novel medicines for the treatment of eye diseases. The private company is based in Taipei, Taiwan. The company's current pipeline includes potential blockbuster drugs such as ag-73305 for the treatment of DME, NAMD, and other retinal diseases, as well as ag-80308 for dry eye disease. The company was founded by Chih Lung Shen and Chih Ming Chen. Madhu Cherukury has been the CEO of the company since 2014. | Health Technology |
| Noratech Pharmaceuticals, Inc. |
- Borsa valori
- Insiders
- Chih Lung Shen
- Esperienza
